These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25336481)

  • 1. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
    Uotila S; Silvola JM; Saukko P; Nuutila P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J; Saraste A
    J Ultrasound Med; 2014 Nov; 33(11):1941-8. PubMed ID: 25336481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
    Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals.
    Cho SG; Park KS; Kim J; Kang SR; Kwon SY; Seon HJ; Jabin Z; Kim YJ; Jeong GC; Song M; Song HC; Min JJ; Bom HS
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):129-140. PubMed ID: 27683281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.
    Laitinen I; Marjamäki P; Haaparanta M; Savisto N; Laine VJ; Soini SL; Wilson I; Leppänen P; Ylä-Herttuala S; Roivainen A; Knuuti J
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1461-7. PubMed ID: 16845513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
    Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
    J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
    Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-choline images murine atherosclerotic plaques ex vivo.
    Matter CM; Wyss MT; Meier P; Späth N; von Lukowicz T; Lohmann C; Weber B; Ramirez de Molina A; Lacal JC; Ametamey SM; von Schulthess GK; Lüscher TF; Kaufmann PA; Buck A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):584-9. PubMed ID: 16357314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
    Virta J; Hellberg S; Liljenbäck H; Ståhle M; Silvola JMU; Huusko J; Söderström M; Knuuti J; Nuutila P; Ylä-Herttuala S; Gomez MF; Roivainen A; Saraste A
    Atherosclerosis; 2020 Jul; 305():64-72. PubMed ID: 32386751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.
    Rogers IS; Nasir K; Figueroa AL; Cury RC; Hoffmann U; Vermylen DA; Brady TJ; Tawakol A
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):388-97. PubMed ID: 20394901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease.
    Dou KF; Yang MF; Yang YJ; Jain D; He ZX
    J Nucl Med; 2008 Dec; 49(12):1986-91. PubMed ID: 18997035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction.
    Lee SJ; On YK; Lee EJ; Choi JY; Kim BT; Lee KH
    J Nucl Med; 2008 Aug; 49(8):1277-82. PubMed ID: 18632820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
    Fifer KM; Qadir S; Subramanian S; Vijayakumar J; Figueroa AL; Truong QA; Hoffmann U; Brady TJ; Tawakol A
    J Am Coll Cardiol; 2011 Feb; 57(8):971-6. PubMed ID: 21329844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
    Tang K; Lin J; Ji X; Lin T; Sun D; Zheng X; Wang L
    J Nucl Cardiol; 2021 Apr; 28(2):610-620. PubMed ID: 31077075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.